1. Home
  2. STKE vs NSRX Comparison

STKE vs NSRX Comparison

Compare STKE & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

STKE

Sol Strategies Inc.

HOLD

Current Price

$1.27

Market Cap

38.3M

Sector

N/A

ML Signal

HOLD

NSRX

Nasus Pharma Ltd. Ordinary Shares

HOLD

Current Price

$2.88

Market Cap

32.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STKE
NSRX
Founded
2002
2019
Country
Canada
Israel
Employees
N/A
7
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.3M
32.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
STKE
NSRX
Price
$1.27
$2.88
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$19.67
AVG Volume (30 Days)
210.9K
40.7K
Earning Date
05-15-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$552.94
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.85
$1.98
52 Week High
$7.75
$9.99

Technical Indicators

Market Signals
Indicator
STKE
NSRX
Relative Strength Index (RSI) 43.65 49.51
Support Level $1.15 $2.04
Resistance Level $1.65 $3.58
Average True Range (ATR) 0.13 0.30
MACD -0.04 -0.01
Stochastic Oscillator 25.42 25.51

Price Performance

Historical Comparison
STKE
NSRX

About STKE Sol Strategies Inc.

Sol Strategies Inc is engaged in investing in blockchain technologies and crypto currencies. Company executes its Investment Objective through three lines of effort: Treasury management: Maintaining a core portfolio of cryptocurrencies for long-term growth, enhanced with risk management strategies to minimize volatility, and generating yield through lending, staking, and liquidity provisioning; Private equity focused on early stage companies in the DeFi and blockchain sectors; and Active investments to generate yield through strategic activities, including Bitcoin mining and stalking and validating Solana.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: